Janus Henderson Group PLC Xenon Pharmaceuticals Inc. Transaction History
Janus Henderson Group PLC
- $182 Billion
- Q2 2024
A detailed history of Janus Henderson Group PLC transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 1,045,257 shares of XENE stock, worth $47 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,045,257
Previous 941,569
11.01%
Holding current value
$47 Million
Previous $40.5 Million
0.54%
% of portfolio
0.02%
Previous 0.02%
Shares
10 transactions
Others Institutions Holding XENE
# of Institutions
221Shares Held
70.6MCall Options Held
59.7KPut Options Held
60.7K-
Avoro Capital Advisors LLC New York, NY5.67MShares$255 Million3.02% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.42MShares$199 Million1.86% of portfolio
-
Wellington Management Group LLP Boston, MA3.83MShares$172 Million0.03% of portfolio
-
Commodore Capital LP New York, NY2.75MShares$124 Million9.63% of portfolio
-
Capital World Investors Los Angeles, CA2.68MShares$121 Million0.02% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.8B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...